T. Rowe Price Associates
OCGN icon

T. Rowe Price Associates’s Ocugen OCGN Stock Holding History

T. Rowe Price Associates’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-123,718
Closed -$88K – 3123
2025
Q1 		$88K Buy
123,718
+10,646
+9% +$7.36K ﹤0.01% 2848
2024
Q4 		$91K Sell
113,072
-122,788
-52% -$112K ﹤0.01% 2846
2024
Q3 		$235K Sell
235,860
-32,960
-12% -$45.2K ﹤0.01% 2590
2024
Q2 		$417K Buy
268,820
+81,720
+44% +$127K ﹤0.01% 2264
2024
Q1 		$307K Hold
187,100
– – ﹤0.01% 2422
2023
Q4 		$108K Buy
187,100
+93,000
+99% +$37.3K ﹤0.01% 2708
2023
Q3 		$38K Buy
94,100
+62,800
+201% +$31K ﹤0.01% 2805
2023
Q2 		$17K Sell
31,300
-137,003
-81% -$87.8K ﹤0.01% 2868
2023
Q1 		$144K Buy
168,303
+4,571
+3% +$4.98K ﹤0.01% 2609
2022
Q4 		$213K Buy
163,732
+26,910
+20% +$41.9K ﹤0.01% 2503
2022
Q3 		$244K Buy
136,822
+12,800
+10% +$31.9K ﹤0.01% 2470
2022
Q2 		$282K Sell
124,022
-6,220
-5% -$14.9K ﹤0.01% 2471
2022
Q1 		$430K Buy
130,242
+2,609
+2% +$9.17K ﹤0.01% 2405
2021
Q4 		$581K Buy
127,633
+21,576
+20% +$163K ﹤0.01% 2315
2021
Q3 		$761K Buy
106,057
+65,800
+163% +$483K ﹤0.01% 2183
2021
Q2 		$323K Buy
40,257
+27,957
+227% +$236K ﹤0.01% 2571
2021
Q1 		$84K Buy
+12,300
New +$81.8K ﹤0.01% 2792

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

T. Rowe Price Associates's OCGN Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 123,718 shares — an estimated $88K sold.

T. Rowe Price Associates first reported a position in OCGN in Q1 2021 and held it in 17 quarters. The position peaked at $761K in Q3 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 123,718 Ocugen shares in Q2 2025, an estimated $88K.
  • T. Rowe Price Associates first reported a position in Ocugen in Q1 2021 and held it in 17 quarters.
  • T. Rowe Price Associates's Ocugen position peaked at $761K in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.